Epalolimab Tovolimab (QL1706)

epalomab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Epalolimab Tovolimab (QL1706), covering 2025-12-09 to 2025-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors [Phase 1, Phase 2]

See pricing